Cargando…
Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
OBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer’s disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 20...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898610/ https://www.ncbi.nlm.nih.gov/pubmed/35042283 http://dx.doi.org/10.30773/pi.2021.0335 |
_version_ | 1784663693482524672 |
---|---|
author | Roh, Hyun Woong Kim, Na-Rae Lee, Dong-gi Cheong, Jae-Youn Seo, Sang Won Choi, Seong Hye Kim, Eun-Joo Cho, Soo Hyun Kim, Byeong C. Kim, Seong Yoon Kim, Eun Young Chang, Jaerak Lee, Sang Yoon Yoon, Dukyong Choi, Jin Wook An, Young-Sil Kang, Hee Young Shin, Hyunjung Park, Bumhee Son, Sang Joon Hong, Chang Hyung |
author_facet | Roh, Hyun Woong Kim, Na-Rae Lee, Dong-gi Cheong, Jae-Youn Seo, Sang Won Choi, Seong Hye Kim, Eun-Joo Cho, Soo Hyun Kim, Byeong C. Kim, Seong Yoon Kim, Eun Young Chang, Jaerak Lee, Sang Yoon Yoon, Dukyong Choi, Jin Wook An, Young-Sil Kang, Hee Young Shin, Hyunjung Park, Bumhee Son, Sang Joon Hong, Chang Hyung |
author_sort | Roh, Hyun Woong |
collection | PubMed |
description | OBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer’s disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 2016 to December 2020. All participants underwent clinical assessments, basic blood tests, and standardized neuropsychological tests (n=1,013). We performed brain magnetic resonance imaging (MRI, n=817), brain amyloid positron emission tomography (PET, n=713), single nucleotide polymorphism microarray chip (K-Chip, n=949), locomotor activity assessment (actigraphy, n=200), and patient-derived dermal fibroblast sampling (n=175) on a subset of participants. RESULTS: The mean age was 72.8 years, and 658 (65.0%) were females. Based on clinical assessments, total of 168, 534, 211, 80, and 20 had subjective cognitive decline, mild cognitive impairment (MCI), Alzheimer’s dementia, vascular dementia, and other types of dementia or not otherwise specified, respectively. Based on neuroimaging biomarkers and cognition, 199, 159, 78, and 204 were cognitively normal (CN), Alzheimer’s disease (AD)-related cognitive impairment, vascular cognitive impairment, and not otherwise specified due to mixed pathology (NOS). Each group exhibited many differences in various clinical, neuropsychological, and neuroimaging results at baseline. Baseline characteristics of BICWALZS participants in the MCI, AD, and vascular dementia groups were generally acceptable and consistent with 26 worldwide dementia cohorts and another independent AD cohort in Korea. CONCLUSION: The BICWALZS is a prospective and longitudinal study assessing various clinical and biomarker characteristics in older adults with cognitive complaints. Details of the recruitment process, methodology, and baseline assessment results are described in this paper. |
format | Online Article Text |
id | pubmed-8898610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Neuropsychiatric Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-88986102022-03-11 Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS Roh, Hyun Woong Kim, Na-Rae Lee, Dong-gi Cheong, Jae-Youn Seo, Sang Won Choi, Seong Hye Kim, Eun-Joo Cho, Soo Hyun Kim, Byeong C. Kim, Seong Yoon Kim, Eun Young Chang, Jaerak Lee, Sang Yoon Yoon, Dukyong Choi, Jin Wook An, Young-Sil Kang, Hee Young Shin, Hyunjung Park, Bumhee Son, Sang Joon Hong, Chang Hyung Psychiatry Investig Original Article OBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer’s disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 2016 to December 2020. All participants underwent clinical assessments, basic blood tests, and standardized neuropsychological tests (n=1,013). We performed brain magnetic resonance imaging (MRI, n=817), brain amyloid positron emission tomography (PET, n=713), single nucleotide polymorphism microarray chip (K-Chip, n=949), locomotor activity assessment (actigraphy, n=200), and patient-derived dermal fibroblast sampling (n=175) on a subset of participants. RESULTS: The mean age was 72.8 years, and 658 (65.0%) were females. Based on clinical assessments, total of 168, 534, 211, 80, and 20 had subjective cognitive decline, mild cognitive impairment (MCI), Alzheimer’s dementia, vascular dementia, and other types of dementia or not otherwise specified, respectively. Based on neuroimaging biomarkers and cognition, 199, 159, 78, and 204 were cognitively normal (CN), Alzheimer’s disease (AD)-related cognitive impairment, vascular cognitive impairment, and not otherwise specified due to mixed pathology (NOS). Each group exhibited many differences in various clinical, neuropsychological, and neuroimaging results at baseline. Baseline characteristics of BICWALZS participants in the MCI, AD, and vascular dementia groups were generally acceptable and consistent with 26 worldwide dementia cohorts and another independent AD cohort in Korea. CONCLUSION: The BICWALZS is a prospective and longitudinal study assessing various clinical and biomarker characteristics in older adults with cognitive complaints. Details of the recruitment process, methodology, and baseline assessment results are described in this paper. Korean Neuropsychiatric Association 2022-02 2022-01-19 /pmc/articles/PMC8898610/ /pubmed/35042283 http://dx.doi.org/10.30773/pi.2021.0335 Text en Copyright © 2022 Korean Neuropsychiatric Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Roh, Hyun Woong Kim, Na-Rae Lee, Dong-gi Cheong, Jae-Youn Seo, Sang Won Choi, Seong Hye Kim, Eun-Joo Cho, Soo Hyun Kim, Byeong C. Kim, Seong Yoon Kim, Eun Young Chang, Jaerak Lee, Sang Yoon Yoon, Dukyong Choi, Jin Wook An, Young-Sil Kang, Hee Young Shin, Hyunjung Park, Bumhee Son, Sang Joon Hong, Chang Hyung Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS |
title | Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS |
title_full | Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS |
title_fullStr | Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS |
title_full_unstemmed | Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS |
title_short | Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS |
title_sort | baseline clinical and biomarker characteristics of biobank innovations for chronic cerebrovascular disease with alzheimer’s disease study: bicwalzs |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898610/ https://www.ncbi.nlm.nih.gov/pubmed/35042283 http://dx.doi.org/10.30773/pi.2021.0335 |
work_keys_str_mv | AT rohhyunwoong baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT kimnarae baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT leedonggi baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT cheongjaeyoun baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT seosangwon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT choiseonghye baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT kimeunjoo baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT chosoohyun baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT kimbyeongc baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT kimseongyoon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT kimeunyoung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT changjaerak baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT leesangyoon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT yoondukyong baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT choijinwook baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT anyoungsil baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT kangheeyoung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT shinhyunjung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT parkbumhee baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT sonsangjoon baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs AT hongchanghyung baselineclinicalandbiomarkercharacteristicsofbiobankinnovationsforchroniccerebrovasculardiseasewithalzheimersdiseasestudybicwalzs |